Transplanted Hearts Adopt Their Host's Biological Age, Harvard Preprint Finds
A Harvard preprint shows transplanted hearts shift their epigenetic age toward the recipient's, with mitochondrial gene programs following suit.
Summary
A new Harvard preprint study reveals that when hearts are transplanted between mice of different ages, the donor heart's epigenetic age shifts toward the recipient's biological age — not the other way around. Young hearts placed in old mice developed older methylation patterns, while old hearts in young mice looked molecularly younger. Gene expression data reinforced this: mitochondrial energy programs were suppressed in young hearts inside old bodies and activated in old hearts inside young bodies. The researchers also examined human transplant data, suggesting this phenomenon may extend to people. The findings imply that the systemic environment — not just the organ's own history — shapes its biological aging, with major implications for expanding donor pools and potentially using organ replacement as a rejuvenation strategy.
Detailed Summary
A preprint from Harvard Medical School offers striking evidence that a transplanted heart's biological age is not fixed — it bends toward the age of the body it lives in. This challenges the assumption that donor organ quality is determined solely by the donor's age and opens new questions about organ transplantation as a tool for rejuvenation.
Researchers transplanted hearts between young, middle-aged, and old mice of the same inbred strain, C57BL/6, leaving the recipient's native heart in place to serve as a direct comparison. Four to six months post-transplant, three independent epigenetic clocks consistently showed that the graft's biological age had shifted toward the recipient's age. Young hearts in old mice accumulated older-looking DNA methylation patterns; old hearts in young mice showed the reverse.
The effect was largely one-directional. While the transplanted heart clearly responded to its new systemic environment, the recipient's native heart, liver, and blood showed no consistent epigenetic shift attributable to the graft. This asymmetry suggests the body exerts a powerful environmental signal on foreign tissue without being meaningfully altered by it in return.
RNA sequencing deepened the picture. Gene expression profiles in the grafts mirrored established aging signatures or longevity-intervention signatures depending on recipient age. The strongest signal came from mitochondrial pathways: energy-related gene programs were downregulated in young hearts inside old bodies and upregulated in old hearts inside young bodies. The researchers extended the analysis to a human hospital transplant dataset, suggesting this biology is not confined to mice.
For longevity science, the implications are significant. If the systemic environment can molecularly rejuvenate an old organ, then interventions targeting that environment — rather than the organ itself — may preserve or restore function. Practically, these findings could support using hearts from older donors without assuming fixed biological decline, though the work remains a preprint and has not yet been peer-reviewed.
Key Findings
- Transplanted hearts' epigenetic age shifts toward the recipient's age, confirmed by three independent epigenetic clocks.
- Old hearts placed in young mice acquired younger molecular profiles; young hearts in old mice aged faster epigenetically.
- Mitochondrial energy gene programs were strongly suppressed or activated depending on whether the recipient was older or younger.
- The host body shaped the graft's biology without its own epigenetic age being measurably altered by the donor heart.
- Human transplant data from a hospital dataset suggest this systemic age-transfer effect may occur in people as well.
Methodology
This is a news report summarizing a Harvard preprint that has not yet been peer-reviewed. The mouse study used a rigorous within-animal control design (graft versus native heart in the same recipient) and three epigenetic clocks, strengthening internal consistency; human data are preliminary and dataset details were not fully disclosed in the article excerpt.
Study Limitations
The study is a preprint and has not completed peer review, so findings should be treated as preliminary. The mouse model used heterotopic transplantation with the native heart retained, which differs from standard clinical transplantation. The human dataset details were not fully described in the available article excerpt, limiting assessment of that component's strength.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: